Results

Total Results: 439 records

Showing results for "diabetes treatment".
Users also searched for: diabetes guidelines

  1. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
    November 01, 2014 - Potential harms also include side effects or complications of treatments. … Long-term harms of HIV antiretroviral therapy. Sexually transmitted infections 2. … Studies are needed that include psychotherapy and combined treatments and focus on MDD alone, as well … inhibitors and complementary or alternative treatments). … Studies on the effectiveness of antiretroviral therapy, adherence to treatment, and behavioral counseling
  2. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hepatitis-c-screening
    December 21, 2017 - What are the harms of currently recommended antiviral treatments? * 9.    … 7, and 8 include those defined by age, race/ethnicity, sex, drug use, receipt of maximally assisted therapy … clinical outcomes (KQ 9) Populations Persons with HCV infection being treated with antiviral therapy … behavioral health care; subpopulations of interest include drug use, persons using medication-assisted therapies … age; morbidity outcomes include extrahepatic manifestations of HCV infection, such as depression and diabetes
  3. www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-prophylaxis-myocardial-infarction-preventive-medication-1996
    January 01, 1996 - factors for coronary heart disease are smoking, high blood pressure, elevated serum cholesterol, obesity, diabetes … discuss aspirin prophylaxis with men who have risk factors for MI (e.g., high blood cholesterol, smoking, diabetes … risks of aspirin therapy before beginning treatment. … Foster JW, Hart RG Antithrombotic therapy for cerebrovascular disease: prevention and treatment of stroke … Fuster V, Dyken ML, Vokonas PS, et al Aspirin as a therapeutic agent in cardiovascular disease.
  4. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-iii-uspstf-litwatch-process
    April 01, 2019 - Topics of interest include screening, preventive services, effectiveness of early treatment of screen-detected … College of Preventive Medicine American Osteopathic Association American Cancer Society American Diabetes
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/N3VeYbr4ZdhZfqsw3ErLHE
    November 01, 2014 - Other factors, including treatment and control of diabetes and hyperlipidemia, are also reported to be … beyond current standard medical therapy. … Prevalence of hypertension in CREST and the SAPPHIRE trial was 85% to 88%, prevalence of diabetes in … and benefit beyond standard preventive treatments based on traditional cardio- vascular risk factors … of medical and surgical treatments, including the potential incremen- tal benefit of CEA.
  6. www.uspreventiveservicestaskforce.org/uspstf/recommendation/healthy-diet-and-physical-activity-counseling-for-cvd-prevention-in-adults-2012
    June 15, 2012 - Recommendation Grade General adult population without a known diagnosis of hypertension, diabetes … Population General adult population without a known diagnosis of hypertension, diabetes … available to quantify a person's 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … It does not apply to adults who have known CVD, hypertension, hyperlipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at  https://hp2010.nhlbihin.net/
  7. www.uspreventiveservicestaskforce.org/uspstf/recommendation/lipid-disorders-in-children-screening
    July 18, 2023 - Dyslipidemia due to homozygous FH or secondary causes (such as diabetes, nephrotic syndrome, or hypothyroidism … USPSTF reviewed 22 fair- to good-quality trials (n = 2257) examining the effectiveness of lipid-lowering treatments … good-quality trials (n = 1008) examining the effectiveness of various nonpharmacologic lipid-lowering treatments … A fair-quality observational study (n = 9393) evaluating the association of statins and new-onset diabetes … showed no difference in new diabetes diagnoses over up to 9 years of follow-up in individuals taking
  8. www.uspreventiveservicestaskforce.org/uspstf/recommendation/aspirin-for-the-prevention-of-cardiovascular-disease-preventive-medication-2009
    March 15, 2009 - Thus, decisions about aspirin therapy should consider the overall risk for stroke and gastrointestinal … Treatment The optimum dose of aspirin for preventing cardiovascular disease events is not known. … among persons whose risk is sufficiently high for the benefits to outweigh the risks associated with treatment … prevention of stroke in women whose risk is sufficiently high for the benefits to outweigh the harms of treatment … from the American Heart Association and the American Diabetes Association.
  9. www.uspreventiveservicestaskforce.org/home/getfilebytoken/2_e9yUNkzrtkkNKmn7YtCU
    September 01, 2012 - cardiovascular morbidity and mortality in adults without known CVD, hypertension, hyperlipidemia, or diabetes … Population: General adult population without a known diagnosis of hypertension, diabetes, hyperlipidemia … available to quantify a person’s 10-year risk for cardiac events, such as the Framingham-based Adult Treatment … It does not ap- ply to adults who have known CVD, hypertension, hyper- lipidemia, or diabetes. … The Framingham-based Adult Treatment Panel III calculator (available at http://hp2010.nhlbihin.net/atpiii
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cardiovascular-diseas/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    October 07, 2013 - sex, smoking status, race/ethnicity, 10-year cardiovascular risk, or related risk conditions (e.g., diabetes … age, sex, smoking status, race/ethnicity, 10-year cardiovascular risk, related risk conditions (e.g., diabetes … available cardiovascular risk prediction tools commonly used in practice are good candidates to guide therapeutic … nonoral, nontablet forms of aspirin; exposure of less than 12 months Comparisons Placebo or no treatment
  11. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2012%20(2).pdf
    November 01, 2012 - cascade of additional follow-up tests (some of which are invasive and could cause harm) and unnecessary treatments … Potential harms also include side effects or complications of treatments. … (Grade: D) This recommendation applies to postmenopausal women who are considering hormone therapy … Screening and Treatment for Depression in Children 3. … Curry’s health service research has focused on the use and cost effectiveness of tobacco cessation treatments
  12. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening-september-2016
    September 25, 2014 - ‡ Other treatments or combinations Comparisons KQs 1, 4: Screened vs. nonscreened … –5: No comparison; nonconcordant historical controls; comparisons with screening tests or treatments … will be defined based on an initial scan of the published literature, but may include persons with diabetes … 9 months, isoniazid twice weekly by directly observed therapy for 6 or 9 months, rifampin daily for … 4 months, or isoniazid plus rifapentine weekly by directly observed therapy for 3 months.
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan15/depression-in-children-and-adolescents-screening
    September 15, 2013 - attention deficit hyperactivity disorder, anxiety disorders) or chronic physical health conditions (e.g., diabetes … norepinephrine-dopamine reuptake inhibitors (NDRIs), or complementary and alternative medicine (CAM) treatments … sertraline, citalopram, and escitalopram Psychotherapy interventions: Cognitive-behavioral therapy … Paroxetine SNRIs, NDRIs, other types of off-label pharmacological interventions Other therapy … : CAM Electroconvulsive therapy Other interventions that are not primary
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/vmHooQ6ABG9CagdUXv2_rx
    August 25, 2021 - Dyslipidemia due to homozygous FH or secondary causes (such as diabetes, Clinical Review & Education … USPSTF reviewed 22 fair- to good-quality trials (n = 2257) examining the effectiveness of lipid-lowering treatments … good-quality trials (n = 1008) examining the effectiveness of various nonpharmacologic lipid-lowering treatments … A fair-quality observational study (n = 9393) evaluating the as- sociation of statins and new-onset diabetes … showed no difference in new diabetes diagnoses over up to 9 years of follow-up in indi- viduals taking
  15. www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
    January 01, 2018 - identifying tools that can accurately assess people’s risk for a specific disease; and the effectiveness of treatments … Persons who have a family history of diabetes, have a history of gestational diabetes or polycystic … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … Considerations for Implementation: To determine whether a patient is a candidate for statin therapy, … D Hormone Therapy With Combined Estrogen and Progestin in Postmenopausal Women: Primary Prevention
  16. www.uspreventiveservicestaskforce.org/uspstf/recommendation/latent-tuberculosis-infection-screening
    May 02, 2023 - 25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insufficient evidence on screening for and treatment of LTBI in persons with diabetes … tuberculosis exposure, HIV infection, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis
  17. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/unhealthy-alcohol-use-adolescents-adults-behavioral-counseling-interventions
    February 01, 2024 - how structural and social determinants of health affect risk for unhealthy alcohol use and access to treatment … not generalizable to primary care (e.g., psychiatric inpatients, persons who are court-mandated to treatment … Counseling interventions can vary in their approach (e.g., 12-step program, cognitive behavioral therapy … , or motivational enhancement therapy), specific strategies, delivery method (e.g., face-to-face, electronic … settings (e.g., diabetes management and dialysis clinics); research clinics; and office, home, or other
  18. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan142/obstructive-sleep-apnea-in-adults-screening-january-2017
    October 30, 2014 - Is there an association between OSA and incident diabetes? … assessments may occur in sleep laboratories or other settings) KQs 4, 5, 8: For nonsurgical treatments … of allergic rhinitis or similar treatments that might secondarily improve OSA by treating another condition … Studies focusing on potential worsening of OSA that might be caused by treatments for other … or inactive mandibular advancement devices; surgery vs. sham, conservative treatment, or no treatment
  19. www.uspreventiveservicestaskforce.org/uspstf/document/screening-for-hiv-in-pregnant-women-evidence-summary/human-immunodeficiency-virus-hiv-infection-screening-2013
    November 15, 2012 - , with the widespread adoption of routine prenatal screening coupled with the use of more effective therapies … without treatment. … or treatment 22 , 23 , 25 . … ; not clear whether gestational diabetes was diagnosed before initiation of antiretroviral therapy … in the United States and other developed countries, except for randomized trials of antiretroviral therapies
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/KdQef_VDT2kmHDX4ddNWmR
    August 01, 2022 - .25 Some evidence from observational studies has explored the association between poorly controlled diabetes … However, there is insuffi- cient evidence on screening for and treatment of LTBI in persons with diabetes … tuberculosis exposure, HIV infec- tion, risk factors increasing risk of progression to active disease (such as diabetes … Efficacy of various durations of isoniazid preventive therapy for tuberculosis: five years of follow-up … Adverse events with 4 months of rifampin therapy or 9 months of isoniazid therapy for latent tuberculosis

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: